This research showed that patients with systemic complications have significantly higher IL-17 gene expression levels compared to those without, but without correlation with the severity of the AP (no statistically significant differences between mild, moderately severe, and severe AP). This evidence concerns the gene IL17A and alkaline phosphatase measurement.